David Poplack, M.D.
David Poplack, M.D., director of the Texas Children's Cancer Center and deputy director of the Dan L. Duncan Cancer Center at Baylor College of Medicine, also holds the Elise C. Young chair of pediatric oncology at BCM and serves as the chief of the hematology and oncology section in the department of pediatrics.
Poplack is training director of the BCM Pediatric Hematology-Oncology Fellowship Training Program, and is the principal investigator/ program director of a K12 "Pediatric Oncology Clinical Research Training Program" and a T32 "Pediatric Oncology Training Program," both funded by the National Cancer Institute. He is also principal investigator of the National Institutes of Health-funded Pediatric Pharmacology Research Unit at BCM. Poplack is chair of the GCRC Scientific Advisory Committee at BCM.
He is a member of the American Society of Clinical Investigation and has served on numerous editorial boards as well as on committees for the National Institutes of Health, the Food and Drug Administration, and the Institute of Medicine. He is also a member of the External Scientific Advisory Board of the Children's Oncology Group . He has authored 348 publications.
Prior to joining BCM, Poplack served as deputy branch chief of the Pediatric Branch of the NCI and head of its Pharmacology and Experimental Therapeutics Section. His research interests include childhood leukemia, cancer survivorship and the clinical pharmacology of anticancer agents in children.
Poplack is the co-editor of Principles and Practice of Pediatric Oncology, the major textbook in the field. He has an extensive track record of successful mentorship. Many of the trainees previously mentored by Poplack are now leaders in the field of pediatric oncology.
Poplack received his M.D. from Boston University School of Medicine, completed residency at Children's Hospital Medical Center in Boston and went on to a fellowship with the National Cancer Institute.